• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS SYPHILIS; ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS SYPHILIS; ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM Back to Search Results
Model Number SYPHILIS
Device Problem Low Test Results (2458)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/06/2019
Event Type  malfunction  
Manufacturer Narrative
Review of the quality control and external proficiency data did not indicate any issues.The investigation is ongoing.This event occurred in (b)(6).
 
Event Description
The initial reporter received questionable (b)(6) elecsys syphilis results for one patient from cobas 8000 cobas e 602 module serial number (b)(4).The patient information was provided as "multiparous female ((b)(6)) with a history of substance abuse and complicated social history".The patient presented at another facility at (b)(6) gestation with early labor and premature rupture of membranes.The patient had blood work, received betamethasone as well as iv penicillin, and was then transferred to this facility for high risk pregnancy care.On (b)(6) 2019, the syphilis eia result from this other facility was (b)(6) (biorad bioplex).The results from the blood work at the first facility were not provided to this facility.Therefore, the patient had new blood work performed including pre-natal screening blood tests.On (b)(6) 2019, the elecsys syphilis eia result from the cobas e602 was (b)(6).A urine toxicology screen was positive for cocaine and the patient had a history of recent cocaine use.The patient noted taking ibuprofen and smoking cigarettes but no other medications or supplement history.The patient received betamethasone as well as iv ampicillin and erythromycin as per protocol for premature rupture of membranes.The patient¿s contractions ceased and she remained at this facility from (b)(6) 2019 whereupon she was transferred back to the first facility at her request.On (b)(6) 2019, the syphilis eia result from the other facility was (b)(6) (biorad bioplex).On (b)(6) 2019, a frozen aliquot of the (b)(6) 2019 sample was retested and the result from the cobas e602 was (b)(6).At the other facility, the repeat result for this same sample was (b)(6) (biorad bioplex).There was no allegation of an adverse event.
 
Manufacturer Narrative
Sample from the patient was submitted for investigation.The elecsys syphilis result was repeatedly non-reactive using different lots of reagent.The rpr2 result was 0.000 r.U (negative) and tpla2 was 19.6 t.U (reactive).The sample was negative for igm and igg anti-treponemal antibodies.The customer¿s negative elecsys syphilis result could be reproduced and no product problem could be found.The sample is most likely truly negative for elecsys syphilis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS SYPHILIS
Type of Device
ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key8784265
MDR Text Key150876140
Report Number1823260-2019-02561
Device Sequence Number1
Product Code LIP
Combination Product (y/n)N
PMA/PMN Number
K160910
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 10/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberSYPHILIS
Device Catalogue Number06923348190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 06/21/2019
Initial Date FDA Received07/12/2019
Supplement Dates Manufacturer Received06/21/2019
Supplement Dates FDA Received10/07/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age31 YR
-
-